New Key Statistics Module, Z-Score and F-Score
SZSE:301093 Key Ratios
Market Cap ¥ M | 2,874.53 |
Enterprise Value ¥ M | 2,187.62 |
P/E(ttm) | 37.02 |
PE Ratio without NRI | 39.27 |
Forward PE Ratio | 16.76 |
Price/Book | 1.28 |
Price/Sales | 5.01 |
Price/Free Cash Flow | 203.08 |
Price/Owner Earnings | -- |
Payout Ratio % | 1.04 |
Revenue (TTM) ¥ M | 591.00 |
EPS (TTM) ¥ | 0.61 |
Beneish M-Score | -2.59 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -0.20 |
y-y EBITDA Growth Rate % | -21.60 |
EV-to-EBIT | 23.49 |
EV-to-EBITDA | 23.49 |
PEG | -- |
Shares Outstanding M | 127.08 |
Net Margin (%) | 13.66 |
Operating Margin % | 9.37 |
Pre-tax Margin (%) | 15.71 |
Quick Ratio | 9.86 |
Current Ratio | 10.55 |
ROA % (ttm) | 3.13 |
ROE % (ttm) | 3.44 |
ROIC % (ttm) | 2.67 |
Dividend Yield % | 2.66 |
Altman Z-Score | 8.38 |
SZSE:301093 Number of Guru Trades
SZSE:301093 Volume of Guru Trades
Gurus Latest Trades with SZSE:301093
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301093 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jiangsu Hualan New Pharmaceutical Material Co Ltd Insider Transactions
No Available Data